# Phase D2.8 Implementation Report — Stage-2 HbA1c Laboratory Assessment & Two-Stage Cascade Completion

## 1. Executive Summary
Phase D2.8 successfully completes the end-to-end two-stage screening cascade for the dysglycemia research prototype:
$$\text{Stage-1 Non-Lab Intake} \longrightarrow \text{Frozen GAM Inference} \longrightarrow \text{Additive Explanation} \longrightarrow \text{Human Review} \longrightarrow \text{Final Human Referral Decision} \longrightarrow \text{Stage-2 HbA1c Lab Assessment} \longrightarrow \text{Laboratory Range}$$

### Key Milestones Delivered:
1. **Authoritative Medical Reference Lock:** Documented and locked against the American Diabetes Association (ADA) *Standards of Care in Diabetes — 2026 (Section 2)* and cross-checked with NIDDK guidelines under rule identifier `ADA_2026_A1C_RANGE_V1`.
2. **Deterministic Range Service:** Standalone Python domain service `classify_hba1c_range()` using exact `Decimal` arithmetic (`< 5.7%` Normal-range, `5.7%–<6.5%` Prediabetes-range, `≥ 6.5%` Diabetes-range).
3. **Stage2Assessment Model & Migration:** Minimal Django migration `0006_stage2assessment.py` establishing `Stage2Assessment` linked via `OneToOneField(on_delete=PROTECT)` to `HumanReview`.
4. **Authoritative Eligibility Gating:** Stage 2 is strictly accessible **only** when `HumanReview.final_referral_recommended == True`. Reached equally through Accepted Refer or Overridden to Refer. Blocked when final human decision is Do Not Refer.
5. **Two-Step Input Review Experience:** Enter HbA1c $\to$ Server Validation $\to$ Review Value & Preliminary Range $\to$ Confirm $\to$ Persist.
6. **Strict Immutability & Anti-Tampering:** Once confirmed, Stage 2 is permanent and read-only in the UI. Client attempts to submit spoofed ranges or diagnosis fields are rejected/ignored.
7. **Zero Machine Learning Execution:** Zero GAM calls and zero XAI calculations occur during any Stage-2 workflow.
8. **Automated Test Suite Expansion:** 24 new unit and integration tests added, bringing the total suite to **89 passing tests**.
9. **Visual QA:** 8 full-page screenshots captured and archived.

---

## 2. Epistemic Architecture & Medical Governance

| Architecture Dimension | Specification in Phase D2.8 |
| :--- | :--- |
| **Model Type** | **NOT a Machine Learning Model.** Pure deterministic clinical range classification. |
| **GAM Inference Calls** | **0 calls.** (Consumes persisted Stage-1 and Human Review evidence). |
| **XAI Recalculations** | **0 calls.** |
| **Output Semantic Role** | **Laboratory Range Category** (`Normal-range`, `Prediabetes-range`, `Diabetes-range`). |
| **Clinical Diagnosis** | **Prohibited.** Application does not evaluate confirmatory testing criteria or assign diagnosis. |
| **Mandatory Caveat** | *"In the absence of unequivocal hyperglycemia, clinical diagnosis generally requires appropriate confirmatory testing. This prototype does not evaluate whether confirmation has occurred."* |
| **Assay Limitation** | Informational note on laboratory methodology and clinical hematologic context. |

---

## 3. Four-Branch Eligibility Matrix

```
STAGE-1 AI REC        HUMAN REVIEW ACTION       FINAL HUMAN DECISION        STAGE-2 ELIGIBILITY
──────────────────────────────────────────────────────────────────────────────────────────────────
Case A: REFER         Accept Recommendation     Refer for Stage 2           ELIGIBLE (Allowed)
Case B: NO REFER      Override Recommendation   Refer for Stage 2           ELIGIBLE (Allowed)
Case C: REFER         Override Recommendation   Do not refer                BLOCKED (Unavailable)
Case D: NO REFER      Accept Recommendation     Do not refer                BLOCKED (Unavailable)
```

---

## 4. Database Schema & Migration Summary

### Migration: `predictor.0006_stage2assessment`
- **Table:** `predictor_stage2assessment`
- **Model:** `Stage2Assessment`
- **Fields:**
  - `id` (UUIDv4 PK)
  - `human_review_id` (OneToOneField to `HumanReview`, `on_delete=PROTECT`, unique index)
  - `hba1c_percent` (DecimalField, max_digits=4, decimal_places=2)
  - `laboratory_range` (CharField, choices: `normal_range`, `prediabetes_range`, `diabetes_range`)
  - `range_rule_version` (CharField, default `'ADA_2026_A1C_RANGE_V1'`)
  - `entry_method` (CharField, default `'manual'`)
  - `created_at` (DateTimeField, auto_now_add=True)
- **Prohibited fields omitted:** No `diagnosis`, `diabetes_status`, `confirmed_diabetes`, `disease_truth`, `AI_stage2_probability`.

---

## 5. Automated Verification Results

Full suite execution:
```
Ran 89 tests in 0.486s
OK
```

### Coverage Breakdown:
1. `HbA1cRangeServiceUnitTests`:
   - Exact boundary classifications: 5.69 $\to$ normal, 5.70 $\to$ prediabetes, 6.49 $\to$ prediabetes, 6.50 $\to$ diabetes. Exact Decimal `5.7` and `6.5`.
   - Domain safety: floats rejected, negative rejected, zero rejected, >25% rejected, non-numeric rejected.
   - Rule version verified as `ADA_2026_A1C_RANGE_V1`.
2. `Stage2AssessmentModelUnitTests`:
   - Valid creation, OneToOne enforcement (IntegrityError on duplicate review relation), absence of prohibited fields, clean validation rejection on non-referred review, clean validation rejection on tampered range.
3. `Stage2EligibilityMatrixIntegrationTests`:
   - Cases A, B, C, D, E (missing review), F (failed explanation).
4. `Stage2WorkflowAndPersistenceIntegrationTests`:
   - Two-step entry/review/confirm flow, anti-tampering rejection of spoofed ranges, duplicate submission idempotency, immutability of prior stages, zero ML/XAI execution.

---

## 6. Visual QA Screenshot Artifacts
Saved in `design/d2_8/screenshots/`:
1. `01_stage2_entry_accepted_refer.png` (Entry form authorized by Accepted Refer)
2. `02_stage2_entry_overridden_to_refer.png` (Entry form authorized by Overridden to Refer)
3. `03_stage2_input_review.png` (Input Review state with value, preview range, edit, and confirm buttons)
4. `04_stage2_normal_range.png` (Completed result: Normal-range < 5.7%)
5. `05_stage2_prediabetes_range.png` (Completed result: Prediabetes-range 5.7%–<6.5%)
6. `06_stage2_diabetes_range.png` (Completed result: Diabetes-range ≥ 6.5%)
7. `07_stage2_unavailable_no_refer.png` (Screening result with No-Refer: Stage 2 blocked banner)
8. `08_stage2_mobile.png` (Mobile viewport 390px rendering of Stage 2 result)

---

## 7. Master Recap Update Status
`PROJECT_MASTER_RECAP.md` (and `docs/PROJECT_MASTER_RECAP.md`) has been updated with Section 32 documenting Phase D2.8 architecture, frozen ADA 2026 reference rules, `Stage2Assessment` entity, database migration, test count (89 OK), research-governance impact, new learning points, and next phase (D2.9). Historical recap sections remain preserved.

---

## 8. Protected Research Artifact Integrity
All protected artifacts remain 100% byte-identical to baseline hashes:
- `gam_final.pkl`: `204A94FF072EF4F1EDECEBF5A643738C006BBF010F3817B4BB798D3EA6FEF41D`
- `preprocessor.pkl`: `6E56A01993A4A6971EB62C82699C49DA6F31A3ACEC2A1169E07862409F42824D`
- `FINAL_MODEL_SPECIFICATION_LOCKED.md`: `7D2A5EB9C349DABFCA4F5387161C78833C8E996DC302E16955A4D588D68D9EC5`
- `final_test_predictions.csv`: `FAC969A00DF57D6686C36B09E3DE65858E2C744812E0BA3E8765B3F6165B5923`
